FORT MILL, S.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, a wholly owned subsidiary of Flyte Aviation, Inc. (NYSE American: VJET), today announced that its VIVO system has received FDA 510(k) clearance for expanded labeling in its Indications for Use statement. The VIVO system is now cleared for a broader patient population, specifically individuals with structural heart disease (SHD) who are undergoing catheter ablation for monomorphic ventricular tachycardia (VT). Structural Heart Disease (SH ...